Loading quotes...
Forecast
| Buy |
0 |
| Hold |
1 |
| Sell |
1 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Novozymes raises guidance and launches €1bn share buyback after strong Q2 results
Novozymes reported adjusted EBITDA of €419.2m for Q2 and organic growth of 9%, both above consensus estimates. The company raised its full‑year guidance and now expects organic sales growth of 7–8% and an adjusted EBITDA margin at the upper end of 37–38%. Novozymes also announced a €1bn share buyback program (start H2 2026, duration until 2029) and confirmed the acquisition of the remaining 77% of MicroBioGen. The news drove the share price markedly higher and pushed it to a new 52‑week high. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 1.14bn | 7.46% |
| Gross profit | 647.3m | 19.45% |
| Net profit | 187.9m | 36.73% |
| EBITDA | 283.5m | 14.51% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €28.74bn |
Number of shares | 467.6m |
52-week high/low | €68.38 - €45.33 |
Dividend yield | 1.43% |
Dividends TTM | €0.87 |
Beta | 0.62 |
P/E ratio | 40.92 |
PEG ratio | 1.51 |
P/B ratio | 2.57 |
P/S ratio | 5.79 |
Company profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
| Name | NOVOZYMES A/S SPONS.ADR 1 |
| CEO | Ester Baiget |
| Headquarters | Lyngby,
nd USA |
| Website | |
| IPO | 20/01/2010 |
| Employees | 11,641 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | NVZMY |
Frankfurt | NZM.F |
Düsseldorf | NZM.DU |
München | NZM.MU |